Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
Recent Patents on CNS Drug Discovery · 2006
DOI: 10.2174/157488906775245318 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on CNS Drug Discovery, 2006. Verfasst von Shigeyuki Chaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan. s.chaki@po.rd.taisho.…. Die Arbeit wurde bisher 30-mal zitiert (Crossref).
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan. s.chaki@po.rd.taisho.co.jp
Zitieren
APA
Chaki, S., Okubo, T., & Sekiguchi, Y. (2006). Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders. Recent Patents on CNS Drug Discovery. https://doi.org/10.2174/157488906775245318
Vancouver
Chaki S, Okubo T, Sekiguchi Y. Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders. Recent Patents on CNS Drug Discovery. 2006. doi:10.2174/157488906775245318
BibTeX
@article{Chaki2006,
author = {Chaki, Shigeyuki and Okubo, Taketoshi and Sekiguchi, Yoshinori},
title = {Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders},
journal = {Recent Patents on CNS Drug Discovery},
year = {2006},
doi = {10.2174/157488906775245318}
}
EUVIMED